The virus that changed medicine: innovation and collaboration in a global health crisis

This event is the first of a series of live panel discussions available on the new ERS Respiratory Channel. The event is completely free to access but registration is required.

Overview

In a time of extreme difficulty, with unprecedented pressure on health systems, this live discussion will focus on the positive outcomes of the COVID-19 pandemic – highlighting the response of key stakeholders in terms of innovation and improved communications and collaborations, which all help to deliver better outcomes for patients and support healthcare systems worldwide.

The discussion will feature a high-profile panel who represent some of the key stakeholders involved in these developments. The discussion areas will include:

• Distribution and supply of essential medicines and medical devices.
• Novel vaccine development, regulatory approval and delivery.
• Rapid trials for evaluation of new therapies, vaccines, and respiratory devices in a pandemic.
• Better communications/digital health and support for healthcare professionals – and between all key stakeholders.

The panel

ERS President Prof. Anita Simonds and ERS Science Council Chair Prof. Christopher E. Brightling will lead the discussion. They will be joined by a high-profile panel:

• Dr. Hans Kluge – WHO Regional Director for Europe
• Manuela Buxo – Head of Europe at Sanofi Genzyme
• Sir Stephen Holgate – Clinical Professor of Immunopharmacology, University of Southampton/Co-founder of Synairgen
• Sir Menelas Pangalos, EVP & President BioPharmaceuticals R&D, AstraZeneca
• Katrin Pucknat – CEO and President, ResMed Germany